Name: Oliver Chukwujekwu Ezechi

Country: Nigeria


Nigerian Institute of Medical Research, Division of Clinical Science Lagos

Email: Send an Email


Nigerian Institute of Medical Research, Division of Clinical Science Lagos

Research Interests:

Infection, Immunology of Infectious Diseases, Public Health, HIV, Sepsis, Infectious Diseases, Obstetric Delivery, Tuberculosis, Reproductive Medicine, Gynaecological Surgery, Clinical Studies, Prenatal Diagnosis, Screening, Fetal Growth Restriction, Endometriosis, Obstetrics, Questionnaire, Marriage, Fetal Medicine, Cervical Cancer Screening, Hepatitis B, Fetal Development, Prenatal Ultrasonography, Cervical Cancer Prevention, Fetal Growth Retardation, Urology, Maternal Health, Fetal Diseases, Prenatal Care, Reproductive Health, Health Policy, Research Ethics, Cervical Cancer, Gynecology, Incidence, Ethics Committees, Socioeconomics, Fetal Distress, Epi Info, Maternal Mortality.



  1. Implication of First-Line Antiretroviral Therapy Choice on Second-Line Options.
  2. Distinct pattern of TAMs with K65R in patients failing tenofovir-based antiretroviral therapy.
  3. Cytotoxicity testing of aqueous extract of bitter leaf (Vernonia amygdalina Del) and sniper 1000EC (2,3 dichlorovinyl dimethyl phosphate) using the Alium cepa test.
  4. Ethical and Scientific Considerations for the Design And Implementation Of The Prep Demonstration Project In Nigeria.
  5. Behavioral and Sexual Practices of HIV Infected Southwestern Nigerians: Implications for HIV Prevention and Control in the Country.
  6. Tolerability of The Copper- T Intrauterine Device by Acceptors at Jos University Teaching Hospital, Jos, North-Central Nigeria.
  7. Pattern and Rate of Occupational and Non- Occupational Exposures: The Experience of a Major HIV Treatment Centre in Nigeria.
  8. Efficacy and Safety of ‘Fixed Dose’ versus ‘Loose’ Drug Regimens for Treatment of Pulmonary Tuberculosis in Two High TB-Burden African Countries: A Randomized Controlled Trial.
  9. Private Sector Engagement in the National HIV Response in Nigeria: Findings from a Nationally Representative Sample of Stakeholders.
  10. Early versus delayed initiation of highly active antiretroviral therapy for HIV-positive adults with newly diagnosed pulmonary tuberculosis (TB-HAART): A prospective, international, randomised, placebo-controlled trial.
  11. Ezechi OC, Gbajabiamilla TA, Gab-Okafor CV, Oladele DA, Ezeobi PM, Ujah IAO. Contraceptive behavior, practices and associated factors among Nigerian women living with Human Immunodeficiency virus infection. Journal of HIV and Human Reproduction 2013;1(1): 30-35.
  12. Willingness and acceptability of cervical cancer screening among HIV positive Nigerian women.